1. Home
  2. NSYS vs CASI Comparison

NSYS vs CASI Comparison

Compare NSYS & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NSYS
  • CASI
  • Stock Information
  • Founded
  • NSYS 1981
  • CASI 1991
  • Country
  • NSYS United States
  • CASI China
  • Employees
  • NSYS N/A
  • CASI N/A
  • Industry
  • NSYS Industrial Machinery/Components
  • CASI Biotechnology: Pharmaceutical Preparations
  • Sector
  • NSYS Technology
  • CASI Health Care
  • Exchange
  • NSYS Nasdaq
  • CASI Nasdaq
  • Market Cap
  • NSYS 29.0M
  • CASI 33.4M
  • IPO Year
  • NSYS N/A
  • CASI 1996
  • Fundamental
  • Price
  • NSYS $9.19
  • CASI $2.10
  • Analyst Decision
  • NSYS
  • CASI Strong Buy
  • Analyst Count
  • NSYS 0
  • CASI 1
  • Target Price
  • NSYS N/A
  • CASI $6.00
  • AVG Volume (30 Days)
  • NSYS 4.8K
  • CASI 8.5K
  • Earning Date
  • NSYS 03-31-2025
  • CASI 03-31-2025
  • Dividend Yield
  • NSYS N/A
  • CASI N/A
  • EPS Growth
  • NSYS N/A
  • CASI N/A
  • EPS
  • NSYS N/A
  • CASI N/A
  • Revenue
  • NSYS $128,133,000.00
  • CASI $28,537,000.00
  • Revenue This Year
  • NSYS N/A
  • CASI N/A
  • Revenue Next Year
  • NSYS N/A
  • CASI $134.79
  • P/E Ratio
  • NSYS N/A
  • CASI N/A
  • Revenue Growth
  • NSYS N/A
  • CASI N/A
  • 52 Week Low
  • NSYS $8.50
  • CASI $2.04
  • 52 Week High
  • NSYS $19.15
  • CASI $7.67
  • Technical
  • Relative Strength Index (RSI)
  • NSYS 35.74
  • CASI 42.35
  • Support Level
  • NSYS $8.50
  • CASI $2.10
  • Resistance Level
  • NSYS $10.05
  • CASI $2.52
  • Average True Range (ATR)
  • NSYS 0.34
  • CASI 0.21
  • MACD
  • NSYS -0.04
  • CASI 0.00
  • Stochastic Oscillator
  • NSYS 36.78
  • CASI 12.50

About NSYS Nortech Systems Incorporated

Nortech Systems Inc is a United States-based electronic manufacturing services company. It offers value-added engineering, technical and manufacturing services and support including project management, design, testing, prototyping, manufacturing, supply chain management, and post-market services. The company's manufacturing and engineering services include complete medical devices, printed circuit board assemblies, wire and cable assemblies, and complex higher-level electro-mechanical assemblies. It operates in the Medical, Aerospace, Defense and Industrial markets with key revenue coming from Medical device and product manufacturing and related engineering services.

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

Share on Social Networks: